Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $987M | $1.17B | $1.29B | $1.09B | $967M | $1.21B | $1.59B | $1.19B | $1.14B | $1.17B |
| Revenue growth | — | 18.9% | 9.6% | -15.1% | -11.5% | 25.7% | 31.1% | -25.3% | -4.6% | 2.7% |
| Gross profit | $391M | $404M | $377M | $379M | $379M | $442M | $377M | $387M | $419M | $348M |
| Gross margin | 39.7% | 34.4% | 29.3% | 34.8% | 39.2% | 36.4% | 23.7% | 32.5% | 36.9% | 29.8% |
| Operating income | $366M | $374M | $350M | $350M | $353M | $411M | $348M | $358M | $390M | $320M |
| Operating margin | 37.1% | 31.9% | 27.2% | 32.1% | 36.5% | 33.8% | 21.8% | 30.0% | 34.4% | 27.4% |
| Net income | $40.9M | $48.7M | $49.3M | $61.0M | $66.2M | $82.5M | $64.2M | $54.3M | $62.4M | $48.7M |
| Net margin | 4.1% | 4.1% | 3.8% | 5.6% | 6.8% | 6.8% | 4.0% | 4.6% | 5.5% | 4.2% |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $288M | $537M | $436M | $451M | $373M | $408M | $464M | $452M | $485M | $280M |
| Capital expenditures | $300M | $68.9M | $39.9M | $43.7M | $37.0M | $81.2M | $54.1M | $46.8M | $49.0M | $78.8M |
| Free cash flow | -$11.9M | $468M | $396M | $407M | $336M | $327M | $410M | $405M | $436M | $202M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $88.9M | $27.0M | $19.7M | $19.9M | $17.2M | $17.1M | $64.8M | $58.6M | $58.3M | $44.3M |
| Total assets | $1.56B | $1.52B | $1.46B | $1.39B | $1.36B | $1.48B | $1.37B | $1.32B | $1.29B | $1.26B |
| Total liabilities | $634M | $517M | $528M | $441M | $441M | $508M | $468M | $461M | $459M | $454M |
Every figure is extracted from Westlake Chemical Partners LP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.